Dendris Overview

  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

Dendris General Information


Developer of a biotechnological chip designed to perform syndromic diagnosis of infectious bacteria in four hours. The company's chip performs a syndromic test allowing to analyze 11 bacteria simultaneously based on the functionalization of the support by phosphorus dendrimers, enabling clinicians to diagnose causes of illness in a reliable and cost-effectives manner.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Diagnostic Equipment
Other Industries
Primary Office
  • 335 rue du chene vert
  • 31670 Labège
  • France
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Dendris Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 07-Mar-2008 Completed Startup
To view Dendris’s complete valuation and funding history, request access »

Dendris Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Nubbo Accelerator/Incubator 000 0000 000000 0
To view Dendris’s complete investors history, request access »